Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.

J. Seegers; M.A. Vos; P. Flevari; R. Willems; C. Sohns; D. Vollman; L. Luthje; D.T. Kremastinos; V. Flore; M. Meine; A. Tuinenburg; R.C. Myles; D. Simon; J. Brockmoller; T. Friede; G. Hasenfuss; S.E. Lehnart; M. Zabel; 1 EuTrigTreat Clinical Study Investigators

Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.

J. Seegers
, M.A. Vos
, P. Flevari
, R. Willems
, C. Sohns
, D. Vollman
, L. Luthje
, D.T. Kremastinos
, V. Flore
, M. Meine
, A. Tuinenburg
, R.C. Myles
, D. Simon
, J. Brockmoller
, T. Friede
, G. Hasenfuss
, S.E. Lehnart
, M. Zabel
, 1 EuTrigTreat Clinical Study Investigators

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	416-422
Number of pages	7
Journal	Europace
Volume	14
Issue number	3
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22117037

Cite this

Seegers, J., Vos, M. A., Flevari, P., Willems, R., Sohns, C., Vollman, D., Luthje, L., Kremastinos, D. T., Flore, V., Meine, M., Tuinenburg, A., Myles, R. C., Simon, D., Brockmoller, J., Friede, T., Hasenfuss, G., Lehnart, S. E., Zabel, M., & EuTrigTreat Clinical Study Investigators, . (2012). Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace, 14(3), 416-422. http://www.ncbi.nlm.nih.gov/pubmed/22117037

@article{08d16b2117bb4d7ea6bcb6b38969065e,

title = "Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.",

author = "J. Seegers and M.A. Vos and P. Flevari and R. Willems and C. Sohns and D. Vollman and L. Luthje and D.T. Kremastinos and V. Flore and M. Meine and A. Tuinenburg and R.C. Myles and D. Simon and J. Brockmoller and T. Friede and G. Hasenfuss and S.E. Lehnart and M. Zabel and \{EuTrigTreat Clinical Study Investigators\}, 1",

year = "2012",

language = "English",

volume = "14",

pages = "416--422",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "3",

}

Seegers, J, Vos, MA, Flevari, P, Willems, R, Sohns, C, Vollman, D, Luthje, L, Kremastinos, DT, Flore, V, Meine, M, Tuinenburg, A, Myles, RC, Simon, D, Brockmoller, J, Friede, T, Hasenfuss, G, Lehnart, SE, Zabel, M & EuTrigTreat Clinical Study Investigators 2012, 'Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.', Europace, vol. 14, no. 3, pp. 416-422. <http://www.ncbi.nlm.nih.gov/pubmed/22117037>

Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. / Seegers, J.; Vos, M.A.; Flevari, P. et al.
In: Europace, Vol. 14, No. 3, 2012, p. 416-422.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.

AU - Seegers, J.

AU - Vos, M.A.

AU - Flevari, P.

AU - Willems, R.

AU - Sohns, C.

AU - Vollman, D.

AU - Luthje, L.

AU - Kremastinos, D.T.

AU - Flore, V.

AU - Meine, M.

AU - Tuinenburg, A.

AU - Myles, R.C.

AU - Simon, D.

AU - Brockmoller, J.

AU - Friede, T.

AU - Hasenfuss, G.

AU - Lehnart, S.E.

AU - Zabel, M.

AU - EuTrigTreat Clinical Study Investigators, 1

PY - 2012

Y1 - 2012

M3 - Article

SN - 1099-5129

VL - 14

SP - 416

EP - 422

JO - Europace

JF - Europace

IS - 3

ER -